E-ISSN 2149-388X | ISSN 2149-0430
 
2024, Vol: 10, Issue: 1
10 / 1Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

Cover Letter
License Agreement
Title Page

Original Article 


Evaluating the Efficiency of the Ottawa Risk Scale in Assessing Adverse Outcomes in COPD Patients Presenting to the Emergency Department

Oya Akpinar Oruc, Serife Ozdinc, Hulya Sevil.


Abstract
Introduction: Chronic Obstructive Pulmonary Disease (COPD) exacerbations present significant challenges in emergency care settings. Predictive tools like the Ottawa Risk Scale (ORS) can potentially enhance early patient management. We aimed to assess the reliability and efficiency of the ORS among COPD in emergency departments.
Materials and Methods: The study reviewed 75 patients presenting with COPD exacerbations were evaluated using the ORS. The ORS categorized patients into four risk groups: Low, Medium, High, and Very High. Clinical characteristics, blood gas analyses, and imaging results were documented.
Results: Clinical symptoms were prevalent across all risk categories, but a significant association was found between smoking history and ORS categorization (p=0.042), oxygen saturation levels (p=0.043), initial PaO2 levels (p=0.013), initial and post-treatment PaCO2 (p=0.008, p=0.003 respectively), and pathological X-ray findings (p=0.005). The mMRC scale showed a correlation with ORS categorization (p=0.0001). The High and Very High-risk groups had higher hospitalization rates and adverse outcomes than Low and Medium risk.
Conclusion: The ORS is a promising tool for predicting short-term adverse outcomes in COPD within emergency settings. This study underscores its potential utility in aiding clinical decision-making, guiding interventions, and improving patient outcomes.

Key words: COPD exacerbations, Ottawa risk scale, emergency department, mMRC scale


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Oya Akpinar Oruc
Articles by Serife Ozdinc
Articles by Hulya Sevil
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Oruc OA, Ozdinc S, Sevil H. Evaluating the Efficiency of the Ottawa Risk Scale in Assessing Adverse Outcomes in COPD Patients Presenting to the Emergency Department. Ulutas Med J. 2023; 9(3): 128-136. doi:10.5455/umj.20230822072102

Web Style

Oruc OA, Ozdinc S, Sevil H. Evaluating the Efficiency of the Ottawa Risk Scale in Assessing Adverse Outcomes in COPD Patients Presenting to the Emergency Department. https://www.ulutasmedicaljournal.com/?mno=166475 [Access: March 06, 2024]. doi:10.5455/umj.20230822072102

AMA (American Medical Association) Style

Oruc OA, Ozdinc S, Sevil H. Evaluating the Efficiency of the Ottawa Risk Scale in Assessing Adverse Outcomes in COPD Patients Presenting to the Emergency Department. Ulutas Med J. 2023; 9(3): 128-136. doi:10.5455/umj.20230822072102


Vancouver/ICMJE Style

Oruc OA, Ozdinc S, Sevil H. Evaluating the Efficiency of the Ottawa Risk Scale in Assessing Adverse Outcomes in COPD Patients Presenting to the Emergency Department. Ulutas Med J. (2023), [cited March 06, 2024]; 9(3): 128-136. doi:10.5455/umj.20230822072102


Harvard Style

Oruc, O. A., Ozdinc, . S. & Sevil, . H. (2023) Evaluating the Efficiency of the Ottawa Risk Scale in Assessing Adverse Outcomes in COPD Patients Presenting to the Emergency Department. Ulutas Med J, 9 (3), 128-136. doi:10.5455/umj.20230822072102


Turabian Style

Oruc, Oya Akpinar, Serife Ozdinc, and Hulya Sevil. 2023. Evaluating the Efficiency of the Ottawa Risk Scale in Assessing Adverse Outcomes in COPD Patients Presenting to the Emergency Department. THE ULUTAS MEDICAL JOURNAL, 9 (3), 128-136. doi:10.5455/umj.20230822072102


Chicago Style

Oruc, Oya Akpinar, Serife Ozdinc, and Hulya Sevil. "Evaluating the Efficiency of the Ottawa Risk Scale in Assessing Adverse Outcomes in COPD Patients Presenting to the Emergency Department." THE ULUTAS MEDICAL JOURNAL 9 (2023), 128-136. doi:10.5455/umj.20230822072102


MLA (The Modern Language Association) Style

Oruc, Oya Akpinar, Serife Ozdinc, and Hulya Sevil. "Evaluating the Efficiency of the Ottawa Risk Scale in Assessing Adverse Outcomes in COPD Patients Presenting to the Emergency Department." THE ULUTAS MEDICAL JOURNAL 9.3 (2023), 128-136. Print. doi:10.5455/umj.20230822072102


APA (American Psychological Association) Style

Oruc, O. A., Ozdinc, . S. & Sevil, . H. (2023) Evaluating the Efficiency of the Ottawa Risk Scale in Assessing Adverse Outcomes in COPD Patients Presenting to the Emergency Department. THE ULUTAS MEDICAL JOURNAL, 9 (3), 128-136. doi:10.5455/umj.20230822072102


Author LoginReviewer LoginAbout PublisherOpen Access PolicyEditorial PoliciesEditorial Review PolicyPeer Review PolicyEditorial & Peer Review ProcessAuthor's Rights and ObligationsPublication Ethics and Publication Malpractice StatementConflict of Interest PolicyPlagiarism PolicyProtection of Research Participants (Statement On Human And Animal Rights)Privacy PolicyCorrections, Retractions & Expressions of ConcernSelf-Archiving PoliciesDigital Archiving & Preservation PoliciesStatement of Informed ConsentAdvertising PolicyTerms of UseLicense InformationCopyright Information

About THE ULUTAS MEDICAL JOURNAL

The Ulutas Medical Journal (UMJ) is a 3 monthly (quarterly), open access, double-blind peer-reviewed, an international journal. Writin ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information


Journal Owner
HAYRİYE ZEHRA ULUTAŞ
Phone: +90 (532) 165 96 39​
E-mail: zehrakenanoglu@hotmail.com​
Address: Alaattin Mah. 30. Ada sok. D11 Blok
No:4 Gungor Uydukent Sitesi  Antakya/HATAY

Editor-In-Chief
KEMAL TURKER ULUTAS, MD, Assc. Prof.
Phone: + 90 (555) 491 35 59​
E-mail: drkemalturker@gmail.com
Address: Alaattin Mah. 30. Ada sok. D11 Blok
No:4 Gungor Uydukent Sitesi  Antakya/HATAY

Publisher Information
SCOPEMED Publishing Co. - TURKEY​
E-mail: scopemed@scopemed.org
Web: https://www.scopemed.com/

 

We welcome your submissions, suggestions, comments, or questions. To reach us, please use one of the methods provided on this page or Email us at ulutasmedicaljournal@gmail.com​

We will respond within 48 to 72 hours.